Like other body parts, the brain can be affected by tumors and cancer. The difference, if on other body parts, benign tumors are sometimes not disturbing and harmless, benign tumors in the brain can be very disturbing and life-threatening. Beware of cancer by finding out more about cancer in hope4cancer. The number of parts of the brain that has the function of different body settings to make tumors and brain cancer has very varied symptoms. The symptoms that appear depend on the part of the brain where the tumor appears.
Symptoms of Brain Cancer
1. Common cerebral symptoms
Symptoms may include mild mental changes (psychomotor asthenia), which are felt by the immediate family of the patient: irritability, emotional, labile, forgetful, slowing mental and social activity, loss of initiative and spontaneity, anxiety and depression may be found. This symptom goes progressive and can be found in 2 or 3 cases.
2. A headache
An estimated 1% cause of a headache is a brain tumor and 3% of the early symptoms of brain tumor are a headache. While the advanced symptoms found 70% of cases. The nature of a headache varies from mild and episodic to severe and throbbing, generally getting heavier at night and on waking hours and in situations where intracranial high-pressure elevations occur. The presence of a headache with psychomotor asthenia should be suspected brain tumors.
It is present in 30% of cases and commonly accompanies a headache. It is more common in tumors in the posterior fossa, usually projectile vomiting and not accompanied by nausea.
Seizure spasm can be an early symptom of a brain tumor in 25% of cases, and more than 35% of cases are at an advanced stage. An estimated 2% cause of seizures is a brain tumor. It should be suspected that the cause of seizures is a brain tumor when:
The first seizure rise at the age of more than 25 years
Experiencing post-paralysis paralysis
Experiencing epilepsy status
Resistant to epilepsy drugs
Resurrection is accompanied by other intracranial high-pressure symptoms. Seizures are present in 70% of brain tumors in the cortex, 50% of patients with astrocytoma, 40% in meningioma patients, and 25% in glioblastoma.